These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37793309)

  • 21. Development of a scale-up strategy for Chinese hamster ovary cell culture processes using the k
    Doi T; Kajihara H; Chuman Y; Kuwae S; Kaminagayoshi T; Omasa T
    Biotechnol Prog; 2020 Sep; 36(5):e3000. PubMed ID: 32298540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Process design of a fully integrated continuous biopharmaceutical process using economic and ecological impact assessment.
    Ding C; Ardeshna H; Gillespie C; Ierapetritou M
    Biotechnol Bioeng; 2022 Dec; 119(12):3567-3583. PubMed ID: 36109341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "Organized stress" for robust scale-up of intensified production process with fed-batch seed bioreactor.
    Ben Yahia B; Piednoir A; Dahomais T; Eggermont S; Paul W
    Biotechnol Bioeng; 2023 Sep; 120(9):2509-2522. PubMed ID: 37027375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving product quality and productivity of bispecific molecules through the application of continuous perfusion principles.
    Gomez N; Lull J; Yang X; Wang Y; Zhang X; Wieczorek A; Harrahy J; Pritchard M; Cano DM; Shearer M; Goudar C
    Biotechnol Prog; 2020 Jul; 36(4):e2973. PubMed ID: 31991523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant reduction of lactate and ammonia accumulation in fed-batch cultures: Impact on glycoprotein production and quality.
    Karengera E; Robotham A; Kelly J; Durocher Y; De Crescenzo G; Henry O
    Biotechnol Prog; 2018 Mar; 34(2):494-504. PubMed ID: 29314777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Side-by-side comparability of batch and continuous downstream for the production of monoclonal antibodies.
    David L; Schwan P; Lobedann M; Borchert SO; Budde B; Temming M; Kuerschner M; Alberti Aguilo FM; Baumarth K; Thüte T; Maiser B; Blank A; Kistler V; Weber N; Brandt H; Poggel M; Kaiser K; Geisen K; Oehme F; Schembecker G
    Biotechnol Bioeng; 2020 Apr; 117(4):1024-1036. PubMed ID: 31930482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemometrics and in-line near infrared spectroscopic monitoring of a biopharmaceutical Chinese hamster ovary cell culture: prediction of multiple cultivation variables.
    Clavaud M; Roggo Y; Von Daeniken R; Liebler A; Schwabe JO
    Talanta; 2013 Jul; 111():28-38. PubMed ID: 23622522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addition of valproic acid to CHO cell fed-batch cultures improves monoclonal antibody titers.
    Yang WC; Lu J; Nguyen NB; Zhang A; Healy NV; Kshirsagar R; Ryll T; Huang YM
    Mol Biotechnol; 2014 May; 56(5):421-8. PubMed ID: 24381145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perfusion mammalian cell culture for recombinant protein manufacturing - A critical review.
    Bielser JM; Wolf M; Souquet J; Broly H; Morbidelli M
    Biotechnol Adv; 2018; 36(4):1328-1340. PubMed ID: 29738813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repurposing fed-batch media and feeds for highly productive CHO perfusion processes.
    Kuiper M; Spencer C; Fäldt E; Vuillemez A; Holmes W; Samuelsson T; Gruber D; Castan A
    Biotechnol Prog; 2019 Jul; 35(4):e2821. PubMed ID: 30985083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling the Downstream Processing of Monoclonal Antibodies Reveals Cost Advantages for Continuous Methods for a Broad Range of Manufacturing Scales.
    Hummel J; Pagkaliwangan M; Gjoka X; Davidovits T; Stock R; Ransohoff T; Gantier R; Schofield M
    Biotechnol J; 2019 Feb; 14(2):e1700665. PubMed ID: 29341493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A system identification approach for developing model predictive controllers of antibody quality attributes in cell culture processes.
    Downey B; Schmitt J; Beller J; Russell B; Quach A; Hermann E; Lyon D; Breit J
    Biotechnol Prog; 2017 Nov; 33(6):1647-1661. PubMed ID: 28786215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of pyruvate on primary metabolism and product quality for a high-density perfusion process.
    Caso S; Aeby M; Jordan M; Guillot R; Bielser JM
    Biotechnol Bioeng; 2022 Apr; 119(4):1053-1061. PubMed ID: 35023143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the limits of conventional small-scale CHO fed-batch for accelerated on demand monoclonal antibody production.
    Mahé A; Martiné A; Fagète S; Girod PA
    Bioprocess Biosyst Eng; 2022 Feb; 45(2):297-307. PubMed ID: 34750672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensified perfusion culture (IPC) reduced recombinant protein fragmentation.
    Yan G; Lu X; Sun R; Zhou W; Zhou H
    Biotechnol Prog; 2024; 40(2):e3405. PubMed ID: 37997628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perfusion cell culture for the production of conjugated recombinant fusion proteins reduces clipping and quality heterogeneity compared to batch-mode processes.
    Bielser JM; Chappuis L; Xiao Y; Souquet J; Broly H; Morbidelli M
    J Biotechnol; 2019 Aug; 302():26-31. PubMed ID: 31207262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shift to high-intensity, low-volume perfusion cell culture enabling a continuous, integrated bioprocess.
    Gagnon M; Nagre S; Wang W; Hiller GW
    Biotechnol Prog; 2018 Nov; 34(6):1472-1481. PubMed ID: 30298995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impacts on product quality attributes of monoclonal antibodies produced in CHO cell bioreactor cultures during intentional mycoplasma contamination events.
    Fratz-Berilla EJ; Angart P; Graham RJ; Powers DN; Mohammad A; Kohnhorst C; Faison T; Velugula-Yellela SR; Trunfio N; Agarabi C
    Biotechnol Bioeng; 2020 Sep; 117(9):2802-2815. PubMed ID: 32436993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrocyclones as cell retention devices for an N-1 perfusion bioreactor linked to a continuous-flow stirred tank production bioreactor.
    Kundu AM; Hiller GW
    Biotechnol Bioeng; 2021 May; 118(5):1973-1986. PubMed ID: 33559888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.